We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Neurologic Biological Marker Objectively Identifies PTSD

By HospiMedica International staff writers
Posted on 03 Feb 2010
Specific neural interactions identified using magnetoencephalography (MEG) can serve as a functional neuromarker for posttraumatic stress disorder (PTSD), according to a new study.

Researchers at the University of Minnesota (UMN; Rochester, USA) and the Minneapolis veterans' affairs (VA) Medical Center (MN, USA) conducted a noninvasive measurement of magnetic fields in the brain (which assesses the functional interactions among neural populations), of synchronous neural interactions (SNI) in a group of 74 United States veterans. The researchers found that MEG could successfully differentiate PTSD patients from healthy control subjects with more than 90% accuracy, as determined by externally cross-validated, bootstrap-based analyses. In addition, all but one of 18 patients who were not receiving medications for their disease was correctly classified. The researchers were also able to judge the severity of the trauma, indicating that MEG could also be used to gauge how badly patients are impacted by other brain disorders. The study was published the February 7, 2010, issue of the Journal of Neural Engineering.

"These findings document robust differences in brain function between the PTSD and control groups that can be used for differential diagnosis, and which possess the potential for assessing and monitoring disease progression and effects of therapy,” concluded lead author Apostolos Georgopoulos, M.D., Ph.D., and colleagues of the Brain Sciences Center at UMN.

MEG is an imaging technique used to measure the magnetic fields produced by electrical activity in the brain via extremely sensitive devices such as superconducting quantum interference devices (SQUIDs). Typically, present-day MEG dewars are helmet-shaped and contain as many as 300 sensors that record the interactions in the brain on a millisecond by millisecond basis, much faster than current methods of evaluation such as functional magnetic resonance imaging (fMRI), which takes seconds to record. In order to generate a signal that is detectable, approximately 50,000 active neurons are needed.

Related Links:

University of Minnesota
Minneapolis VA Medical Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Surgical System
Stealth AXiS
Blood Gas Analyzer
i-Check200

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more